•  
  •  
 

Abstract

Pada tahun 2021, Indonesia menempati peringkat pertama dengan kasus COVID-19 terbanyak di ASEAN. Angka kematian COVID-19 di Indonesia sebesar 3,4% dan peringkat ke-5 ditempati oleh Provinsi Sumatera Selatan. Penelitian terdahulu menunjukkan komorbiditas berkontribusi terhadap kematian pasien COVID-19 disertai usia dan jenis kelamin. Penelitian ini bertujuan untuk menganalisis peran usia, jenis kelamin, dan komorbiditas terhadap kondisi akhir pasien COVID-19 di RSUD Siti Fatimah. Metode penelitian menggunakan desain cohort retrospective dengan analisis cox regression pendekatan model proportional hazard. Penelitian ini menggunakan data sekunder yaitu rekam medik pasien terkonfirmasi COVID-19 di RSUD Siti Fatimah dari Januari-Desember 2021 berjumlah 928 pasien yang diambil dengan melibatkan semua sampel yang eligible. Variabel dependen adalah kondisi akhir pasien COVID-19 sedangkan variabel independen yaitu hipertensi, diabetes melitus (DM), penyakit kardiovaskular (CVD), penyakit ginjal, tuberkulosis (TBC), dan penyakit paru obstruktif kronis (PPOK). Penelitian ini menemukan bahwa dari 928 pasien COVID-19 terdapat 79,63% pasien berusia <60 >tahun, 50,11% laki-laki, dan 16,06% mengalami kematian. Hasil analisis menunjukkan bahwa usia, jenis kelamin, dan faktor komorbiditas yaitu hipertensi, DM, CVD, penyakit ginjal, TBC, dan PPOK berhubungan signifikan dengan kondisi akhir pasien COVID-19 (p-value

References

1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar 12;579(7798):270–3.

2. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England Journal of Medicine. 2020 Mar 26;382(13):1199–207.

3. Gómez-Mesa JE, Galindo-Coral S, Montes MC, Muñoz Martin AJ. Thrombosis and Coagulopathy in COVID-19. Curr Probl Cardiol. 2021 Mar;46(3):100742.

4. WHO. WHO Coronavirus (COVID-19) Dashboard [Internet]. 2023 [cited 2023 Mar 13]. Available from: https://covid19.who.int

5. Kementerian Kesehatan RI. Situasi Terkini Perkembangan Coronavirus Disease (Covid-19) [Internet]. Jakarta; 2021 Nov [cited 2023 Mar 13]. Available from: https://infeksiemerging.kemkes.go.id/document/situasi-terkini-perkembangan-coronavirus-disease-covid-19-23-november-2021/view

6. Kemenkes RI. Ikhtisar Mingguan Covid-19 Edisi 13 [Internet]. Jakarta; 2021 Oct [cited 2023 Mar 13]. Available from: https://www.kemkes.go.id/downloads/resources/download/laporan-mingguan-covid/Laporan-Mingguan-Penanganan-Covid-19_18-Okt-2021.pdf

7. PHEOC Kemkes RI. Covid-19 [Internet]. Jakarta; 2023 Mar [cited 2023 Mar 13]. Available from: https://infeksiemerging.kemkes.go.id/dashboard/covid-19

8. Kementerian Kesehatan RI. Profil Kesehatan Indonesia 2021. Jakarta: Kementerian Kesehatan Republik Indonesia; 2022. 192–200 p.

9. Zhan H, Chen H, Liu C, Cheng L, Yan S, Li H, et al. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression. Clinical and Applied Thrombosis/Hemostasis. 2021 Jan 1;27:107602962110109.

10. Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020 Nov 5;71(8):1937–42.

11. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020 Jun;26(6):767–72.

12. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–62.

13. Shang J, Wang Q, Zhang H, Wang X, Wan J, Yan Y, et al. The Relationship Between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China. Am J Med. 2021 Jan;134(1):e6–14.

14. Nanda CCS, Indaryati S, Koerniawan D. Pengaruh Komorbid Hipertensi dan Diabetes Mellitus terhadap Kejadian COVID-19. Jurnal Keperawatan Florence Nightingale. 2021 Dec 29;4(2):68–72.

15. Carter P, Anderson M, Mossialos E. Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective. Eur Heart J. 2020 Jul 14;41(27):2516–8.

16. Peratutan Menteri Kesehatan Republik Indonesia Nomor 23 Tahun 2023 tentang Pedoman Penanggulangan Corona Virus Disease 2019 (COVID-19).

17. Masdalena, Muryanto I, Efendi AS, Yunita J, Gustina T. Faktor Risiko Komorbid pada Kematian COVID-19 di Rumah Sakit X Tahun 2021. Jurnal Kesehatan Masyarakat Mulawarman. 2021 Dec;3(2):105–17.

18. Hidayati S, Adnan N. Faktor-Faktor yang Berhubungan dengan Kematian Pasien COVID-19 Lansia di Ruang Rawat Inap RSUD Kabupaten Karanganyar. Jurnal Epidemiologi Kesehatan Indonesia. 2022 Dec;6(2):69–74.

19. Bhopal R. COVID-19 worldwide: we need precise data by age group and sex urgently. BMJ. 2020 Apr 3;369:m1366.

20. Hong KH, Choi JP, Hong SH, Lee J, Kwon JS, Kim SM, et al. Predictors of mortality in Middle East respiratory syndrome (MERS). Thorax. 2018 Mar;73(3):286–9.

21. Sargiacomo C, Sotgia F, Lisanti MP. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging. 2020 Mar 30;12(8):6511–7.

22. Mehra MR, Ruschitzka F. COVID-19 Illness and Heart Failure: A Missing Link? JACC Heart Fail. 2020 Jun;8(6):512–4.

23. Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020 May;10(5):766–88.

24. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020 May 8;126(10):1456–74.

25. Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020;9(1):601–4.

26. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000 Aug;31(2):578–85.

27. Cattrini C, Bersanelli M, Latocca MM, Conte B, Vallome G, Boccardo F. Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer. Cancers (Basel). 2020 Aug 18;12(8).

28. Karlberg J, Chong DSY, Lai WYY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004 Feb 1;159(3):229–31.

29. Bartz D, Chitnis T, Kaiser UB, Rich-Edwards JW, Rexrode KM, Pennell PB, et al. Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All: A Review. JAMA Intern Med. 2020 Apr 1;180(4):574–83.

30. Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152.

31. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 May;55(5).

32. Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020 Nov 1;180(11):1436–47.

33. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020 Apr;8(4):e21.

34. Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr Metab Cardiovasc Dis. 2021 Mar 10;31(3):745–55.

35. Klimas J, Olvedy M, Ochodnicka-Mackovicova K, Kruzliak P, Cacanyiova S, Kristek F, et al. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats. J Cell Mol Med. 2015 Aug;19(8):1965–74.

36. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020 Oct;36(7):e3319.

37. Guan W jie, Ni Z yi, Hu Y, Liang W hua, Ou C quan, He J xing, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708–20.

38. de Almeida-Pititto B, Dualib PM, Zajdenverg L, Dantas JR, de Souza FD, Rodacki M, et al. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr. 2020;12:75.

39. Lacobellis G. COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Res Clin Pract. 2020 Apr;162:108125.

40. Lens-Pechakova LS. Centenarian Rates and Life Expectancy Related to the Death Rates of Multiple Sclerosis, Asthma, and Rheumatoid Arthritis and the Incidence of Type 1 Diabetes in Children. Rejuvenation Res. 2016 Feb;19(1):53–8.

41. Pablos JL, Galindo M, Carmona L, Lledó A, Retuerto M, Blanco R, et al. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis. 2020 Dec;79(12):1544–9.

42. Khabbazi A, Kavandi H, Paribanaem R, Khabbazi R, Malek Mahdavi A. Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic. Ann Rheum Dis. 2022 Oct;81(10):e200.

43. Chuah SL, Teh CL, Wan Mohd Akbar SA, Cheong YK, Sachdev Manjit Singh B. Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic. Ann Rheum Dis. 2022 Aug;81(8):e144.

44. Hassen LM, Almaghlouth IA, Hassen IM, Daghestani MH, Almohisen AA, Alqurtas EM, et al. Impact of COVID-19 outbreak on rheumatic patients’ perceptions and behaviors: A cross-sectional study. Int J Rheum Dis. 2020 Nov;23(11):1541–9.

45. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5):829–38.

46. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020 May;55(5).

47. Gao Y, Liu M, Chen Y, Shi S, Geng J, Tian J. Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis. J Med Virol. 2021 Jan;93(1):194–6.

48. Chen T, Dai Z, Mo P, Li X, Ma Z, Song S, et al. Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1788–95.

49. Easton A V., Salerno MM, Trieu L, Humphrey E, Kaba F, Macaraig M, et al. Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022. PLOS Global Public Health. 2023 Apr 26;3(4):e0001758.

50. Meza D, Khuder B, Bailey JI, Rosenberg SR, Kalhan R, Reyfman PA. Mortality from COVID-19 in Patients with COPD: A US Study in the N3C Data Enclave. Int J Chron Obstruct Pulmon Dis. 2021 Aug;16:2323–6.

51. Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020 May;55(5).

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.